Browsing Tag

Favipiravir

Cipla Set to Launch Repurposed Drug Favipiravir for COVID-19

Jyoti Singh Jul 28, 2020 0

Cipla has scaled up the process in their manufacturing facility and approached Drug Controller General of India (DCGI) for permission to launch of a repurposed drug Favipiravir for COVID-19 in India. Given that DCGI has given restricted…
Read More...

News

Containing the Deadly COVID-19: Viability of Pooling Technologies

Madhuri Anand Apr 19, 2020 0

Global pandemic COVID-19 is now in 199 countries with reported confirmed cases above two million and mounting death tolls in thousands every day. In the absence of vaccines and medicines to prevent or treat COVID-19, many options have…
Read More...

Our Campaigns

Support & Donate Now

The role of journalism is strongly challenged now more than ever before. It is imperative that the fourth pillar of democracy publish news and views in its most credible form. We at Delhi Post place the highest regard for freedom of expression. We strive to publish the truth and assert credibility over chaos. To safeguard the independent, non-partisan space, we depend on the support of our readers and contributors. Please Donate Now and join us in maintaining this platform which is a voice for every individual with an opinion!